Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Matteucci

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Oncology|February 8, 2013
Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials?Alba Fiorentino, Mario Balducci, Pasquale De Bonis, et al.
Cancers|June 28, 2023
Efficacy of Electrochemotherapy in Breast Cancer Patients of Different Receptor Status: The INSPECT ExperienceClaudia Di Prata, Matteo Mascherini, Alastair MacKenzie Ross, et al.
Clinical & Experimental Metastasis|November 21, 2025
Importance of the timing of combined electrochemotherapy and immunotherapy in the treatment of advanced melanomaErika Gabriella Kis, Matteo Brizio, Giuseppe Riva, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2020
Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: A matched cohort analysis from the InspECT registryGregor Sersa, Matteo Mascherini, Claudia Di Prata, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Frontiers in Oncology|October 7, 2022
Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020)Giulia Bertino, Ales Groselj, Luca G Campana, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 21, 2022
Prospektive Kohortenstudie von InspECT zur Sicherheit und Wirksamkeit der Elektrochemotherapie bei Hauttumoren und Metastasen in Abhängigkeit von UlzerationCarla Sophie Claussen, Graeme Moir, Falk G Bechara, et al.
Neuro-Oncology|May 29, 2021
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIROSilvia Scoccianti, Emanuela Olmetto, Valentina Pinzi, et al.
La Radiologia Medica|December 16, 2024
Ladies project: large database in endometrial cancers for a personalized treatmentRosa Autorino, Raffaella Michela Rinaldi, Gabriella Macchia, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Oncology|February 8, 2013
Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials?Alba Fiorentino, Mario Balducci, Pasquale De Bonis, et al.
Cancers|June 28, 2023
Efficacy of Electrochemotherapy in Breast Cancer Patients of Different Receptor Status: The INSPECT ExperienceClaudia Di Prata, Matteo Mascherini, Alastair MacKenzie Ross, et al.
Clinical & Experimental Metastasis|November 21, 2025
Importance of the timing of combined electrochemotherapy and immunotherapy in the treatment of advanced melanomaErika Gabriella Kis, Matteo Brizio, Giuseppe Riva, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2020
Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: A matched cohort analysis from the InspECT registryGregor Sersa, Matteo Mascherini, Claudia Di Prata, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Frontiers in Oncology|October 7, 2022
Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020)Giulia Bertino, Ales Groselj, Luca G Campana, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 21, 2022
Prospektive Kohortenstudie von InspECT zur Sicherheit und Wirksamkeit der Elektrochemotherapie bei Hauttumoren und Metastasen in Abhängigkeit von UlzerationCarla Sophie Claussen, Graeme Moir, Falk G Bechara, et al.
Neuro-Oncology|May 29, 2021
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIROSilvia Scoccianti, Emanuela Olmetto, Valentina Pinzi, et al.
La Radiologia Medica|December 16, 2024
Ladies project: large database in endometrial cancers for a personalized treatmentRosa Autorino, Raffaella Michela Rinaldi, Gabriella Macchia, et al.
Pageof 6